Average Insider

Where insiders trade, we follow

KalVista Pharmaceuticals, Inc. ($KALV)
Accession: 0001691102-26-000002
Feb 25, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$9.23
Current$16.4373.7% above low, 26.3% below high
52W High$19.00

Filing Information

Accession Number0001691102-26-000002
Form Type4
Filing DateFeb 25, 2026
DocumentView SEC Filing
Transactions
5
Total Shares
18,097
Total Value
$67,668.88

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Common Stock
โ€”Feb 21, 2026Exercise/Conversion3,750โ€”โ€”227,923Directโ€”View Details
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Common Stock
โ€”Feb 22, 2026Exercise/Conversion3,125โ€”โ€”231,048Directโ€”View Details
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Common Stock
โ€”Feb 23, 2026Sale4,347$15.57$67,668.88226,701Directโ€”View Details
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Restricted Stock Unit
(Common Stock)
DerivativeFeb 21, 2026Exercise/Conversion3,750$0.00$0.0045,000Directโ€”View Details
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Restricted Stock Unit
(Common Stock)
DerivativeFeb 22, 2026Exercise/Conversion3,125$0.00$0.0028,125Directโ€”View Details
Version: v26.3.23